Depletion of SLC4A11 causes cell death by apoptosis in an immortalized human corneal endothelial cell line

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 3270-3279

  Liu, Jun ^a   Seet, Li Fong ^a,b   Koh, Li Wei ^a   Venkatraman, Anandalakshmi ^a   Venkataraman, Divya ^a   Mohan, Rajiv R ^c   Praetorius, Jeppe ^d   Bonanno, Joseph A ^e   Aung, Tin ^a,b,f   Vithana, Eranga N ^a,b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c University of Missouri   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e INDIANA UNIVERSITY   (United States)

^f SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 9; CASPASE RECRUITMENT DOMAIN PROTEIN 4; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGEN TYPE 8; FAS ANTIGEN; FIBRONECTIN; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOCORTIN 5; LYMPHOTOXIN BETA RECEPTOR; OSTEOPROTEGERIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN ZO1; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; APOPTOSIS; ARTICLE; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORNEA ENDOTHELIUM; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NICK END LABELING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLC4A11 GENE; WESTERN BLOTTING;

ANION TRANSPORT PROTEINS; ANTIPORTERS; APOPTOSIS; BLOTTING, WESTERN; CELL COUNT; CELL DEATH; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; ENDOTHELIUM, CORNEAL; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84861974117     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8724     Document Type: Article

References (32)

1. Cordat E, Casey JR. Bicarbonate transport in cell physiology and disease. Biocheml J. 2009;417:423-439.
2. Romero MF. Molecular pathophysiology of SLC4 bicarbonate transporters. Curr Opin Nephrol Hypertens. 2005;14:495-501.
3. {thorn}-independent SLC4 anion exchangers. J Exp Biol. 2009;212:1672-1683.
4. {thorn}-coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol Cell. 2004;16:331-341.
5. Vithana EN, Morgan P, Sundaresan P, et al. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet. 2006;38:755-757.
6. Jiao X, Sultana A, Garg P, et al. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11. J Med Genet. 2007;44:64-68.
7. Desir J, Abramowicz M. Congenital hereditary endothelial dystrophy with progressive sensorineural deafness (Harboyan syndrome). Orphanet J Rare Dis. 2008;3:28.
8. Vithana EN, Morgan PE, Ramprasad V, et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet. 2008;17:656-666.
9. Judisch G, Maumenee I. Clinical differentiation of recessive congenital hereditary endothelial dystrophy and dominant hereditary endothelial dystrophy. Am J Ophthalmol. 1978;85: 606-612.
10. Kirkness CM, McCartney A, Rice NS, Garner A, Steele AD. Congenital hereditary corneal oedema of Maumenee: its clinical features, management, and pathology. Br J Ophthalmol. 1987;71:130-144.
11. Ehlers N, Modis L, Moller-Pedersen T. A morphological and functional study of Congenital Hereditary Endothelial Dystrophy. Acta Ophthalmol Scand. 1998;76:314-318.
12. Adamis AP, Filatov V, Tripathi BJ, Tripathi RC. Fuchs' endothelial dystrophy of the cornea. Surv Ophthalmol. 1993;38:149-168.
13. Lopez IA, Rosenblatt MI, Kim C, et al. Slc4a11 gene disruption in mice: cellular targets of sensorineuronal abnormalities. J Biol Chem. 2009;284:26882-26896.
14. Groger N, Frohlich H, Maier H, et al. SLC4A11 prevents osmotic imbalance leading to corneal endothelial dystrophy, deafness, and polyuria. J Bioll Chem. 2010;285:14467-14474.
15. Engelmann K, Bednarz J, Schafer HJ, Friedl P. Isolation and characterization of a mouse monoclonal antibody against human corneal endothelial cells. Exp Eye Res. 2001;73:9-16.
16. Damkier HH, Nielsen S, Praetorius J. Molecular expression of SLC4-derived Na{thorn}-dependent anion transporters in selected human tissues. Am J Physiol. 2007;293:R2136-2146.
17. Jun AS, Meng H, Ramanan N, et al. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum Mol Genet. 2012;21:384-393.
18. Mohan RR, Kim WJ, Mohan RR, Chen L, Wilson SE. Bone morphogenic proteins 2 and 4 and their receptors in the adult human cornea. Invest Ophthalmol Vis Sci. 1998;39:2626-2636.
19. Mohan RR, Possin DE, Mohan RR, Sinha S, Wilson SE. Development of genetically engineered tet HPV16-E6/E7 transduced human corneal epithelial clones having tight regulation of proliferation and normal differentiation. Exp Eye Res. 2003;77:395-407.
20. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.
21. Scheuermann T, Sun Y, Sagner S, Rueger B. Gene Expression analysis of paclitaxel-treated HT29 cells using the xCELLigence system and realtime ready panels. Biotechniques. 2009;46: 557-558.
22. Aldave AJ, Yellore VS, Bourla N, et al. Autosomal recessive CHED associated with novel compound heterozygous mutations in SLC4A11. Cornea. 2007;26:896-900.
23. Desir J, Moya G, Reish O, et al. Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy. J Med Genet. 2007;44:322-326.
24. Park M, Li Q, Shcheynikov N, Muallem S, Zeng W. Borate transport and cell growth and proliferation. Not only in plants. Cell Cycle. 2005;4:24-26.
25. Joyce NC, Navon SE, Roy S, Zieske JD. Expression of cell cycleassociated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci. 1996;37:1566-1575.
26. Kumar S, Flacke JP, Kostin S, Appukuttan A, Reusch HP, Ladilov Y. SLC4A7 sodium bicarbonate co-transporter controls mitochondrial apoptosis in ischaemic coronary endothelial cells. Cardiovasc Res. 2011;89:392-400.
27. Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351:41-58.
28. Vilas GL, Morgan PE, Loganathan SK, Quon A, Casey JR. A biochemical framework for SLC4A11, the plasma membrane protein defective in corneal dystrophies. Biochemistry. 2011; 50:2157-2169.
29. Vilas G, Loganathan S, Quon A, Sundaresan P, Vithana EN, Casey J. Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations. Hum Mutat. 2012;33:419-428.
30. Borderie VM, Baudrimont M, Vallee A, Ereau TL, Gray F, Laroche L. Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci. 2000;41:2501-2505.
31. Li QJ, Ashraf MF, Shen DF, et al. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol. 2001;119:1597-1604.
32. Tuft SJ, Williams KA, Coster DJ. Endothelial repair in the rat cornea. Invest Ophthalmol Vis Sci. 1986;27:1199-1204.